Folgende Informationen sind nur in englischer Sprache verfügbar:
We have the honour to invite you to TRANSCAN-3 JTC2021 International Networking Event "Next generation cancer immunotherapy: targeting the tumour microenvironment" under the “Turkey in Horizon 2020 Phase II” Technical Assistance Projectwhich is co-financed by the EU and the Republic of Turkey and implemented by the Republic of Turkey Ministry of Industry and Technology within the scope of Competitive Sectors Programme.
The event will focus on the forthcoming Joint Transnational Call (JTC2021) "Next generation cancer immunotherapy: targeting the tumour microenvironment"
28 funding organizations from 19 countries are participating in the call. We will bring together up to 500 participants from Europe, Canada, Taiwan and Turkey, coming from research communities, private sector and hospitals. This will not only give you the unique opportunity to connect with a wide variety of stakeholders to discuss project ideas, but also get first-hand information about the TRANSCAN-3 Joint Transnational Call 2021.
Join this event, present your project ideas and discuss them with potential partners in online face-to-face meetings!
Register now and don't miss the opportunity.
Looking forward to seeing you online!
For detailed information, you can contact ncphealth(at)tubitak.gov.tr
For any concerns about registration or any other organisational issues, please contact Mr. Kemal Onur Gungor at K.Gungor(at)idi.ie or Ms. Tugce Eryilmaz at t.eryilmaz(at)idi.ie.
Find more about the new ERA-NET: Sustained collaboration of national and regional programmes in cancer research at https://www.transcanfp7.eu/
TRANSCAN-3 project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 964264. The European Commission (EC) will contribute to JTC2021 in accordance with the ERA-NET Cofund scheme.This event will support the EU Cancer Mission by raising awareness and enabling international cooperation for cancer research.